Dabur India Ltd: FDA regulatory signals

This page aggregates the United States FDA regulatory records that reference Dabur India Ltd in the datasets indexed by this site. Across the ingested data, Dabur India Ltd is associated with 14 recall record(s), 0 drug-shortage record(s), and 0 approval record(s). The most recent dated event attributed to this firm in the indexed data is a recall record dated 2026-06-24. These counts are coverage-limited activity signals derived only from the specific FDA datasets indexed here. They are NOT quality ratings, reputational scores, or judgements about the firm or its products. A higher or lower count reflects how often a firm appears in these particular public records over the ingested window — nothing more. Recalls and shortages are routine parts of pharmaceutical regulation, and their presence here is an administrative fact, not an indication of wrongdoing or of product danger. Use this page as a finding aid to locate the underlying FDA records, then verify every detail against the official source. This page contains regulatory information only and offers no medical advice.

Signal summary

Recall records	14
Shortage records	0
Approval records	0
Most recent record date	2026-06-24
Most recent record type	recall

These counts are not a quality rating. They are coverage-limited activity signals showing how often this firm appears in the indexed FDA recall and shortage records over the ingested window. They are not reputational scores or judgements about the firm or its products.

Recall records

Source limitations

This page is built only from the FDA recall and shortage records this site has ingested. It does not represent the firm's full regulatory history, its approvals, or any data held in sources not indexed here. The ingested window is finite and can lag the live FDA record, so counts and dates reflect a point in time. Every linked record points back to the verifiable official source; confirm details there. This page contains regulatory information only and offers no medical advice, no assessment of product safety, and no recommendation of any kind.

Source & provenance

Official source: https://open.fda.gov/apis/drug/enforcement/
Source dataset: openFDA (enforcement + shortages)
Publication date: Not available
Ingested: 2026-07-28

Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.